Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Host-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model.

Tytuł:
Host-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model.
Autorzy:
Pharo EA; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity Business Unit, Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia.
Williams SM; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity Business Unit, Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia.
Boyd V; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity Business Unit, Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia.
Sundaramoorthy V; CSIRO Australian Animal Health Laboratory (AAHL) Business Unit, ACDP, Geelong, VIC 3220, Australia.; School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia.
Durr PA; CSIRO Australian Animal Health Laboratory (AAHL) Business Unit, ACDP, Geelong, VIC 3220, Australia.
Baker ML; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity Business Unit, Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia.
Źródło:
Viruses [Viruses] 2020 Jun 24; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI
MeSH Terms:
Influenza A Virus, H1N1 Subtype/*physiology
Influenza, Human/*virology
Respiratory Mucosa/*cytology
Respiratory Mucosa/*virology
Animals ; Bronchi/cytology ; Bronchi/virology ; Cells, Cultured ; Chemokines/metabolism ; Cytokines/metabolism ; Dogs ; Host-Pathogen Interactions ; Humans ; Immunity, Innate ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza, Human/epidemiology ; Intercellular Junctions ; Madin Darby Canine Kidney Cells ; Models, Biological ; Mucin 5AC/metabolism ; Pandemics ; Virus Cultivation
References:
Nature. 2009 Aug 20;460(7258):1021-5. (PMID: 19672242)
Front Cell Infect Microbiol. 2018 Oct 08;8:343. (PMID: 30349811)
Inflamm Res. 2019 Jan;68(1):59-74. (PMID: 30306206)
Curr Clin Microbiol Rep. 2019 Mar;6(1):10-17. (PMID: 31592409)
J Virol. 2005 Dec;79(24):15511-24. (PMID: 16306622)
Emerg Infect Dis. 2011 Jun;17(6):1053-5. (PMID: 21749768)
J Mol Biol. 2014 Mar 20;426(6):1210-9. (PMID: 24157441)
Annu Rev Physiol. 2008;70:459-86. (PMID: 17850213)
Mucosal Immunol. 2016 Mar;9(2):287-98. (PMID: 26627458)
Lancet. 2006 Dec 23;368(9554):2211-8. (PMID: 17189032)
Crit Care. 2010;14(6):R203. (PMID: 21062445)
Nat Immunol. 2019 Apr;20(4):493-502. (PMID: 30833792)
Viruses. 2020 Apr 04;12(4):. (PMID: 32260457)
Front Immunol. 2020 Feb 04;11:3. (PMID: 32117216)
J Gen Virol. 2012 Jun;93(Pt 6):1269-1277. (PMID: 22377585)
J Allergy Clin Immunol. 2016 Jan;137(1):278-288.e6. (PMID: 26100084)
Pflugers Arch. 2017 Jan;469(1):135-147. (PMID: 27921210)
Tissue Barriers. 2013 Oct 1;1(4):e24997. (PMID: 24665407)
Am J Respir Crit Care Med. 2008 Dec 15;178(12):1271-81. (PMID: 18787220)
Am J Respir Crit Care Med. 2013 Oct 1;188(7):842-51. (PMID: 23952745)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
Nucleic Acids Res. 2019 Jan 8;47(D1):D786-D792. (PMID: 30304474)
Cell. 2010 Mar 19;140(6):805-20. (PMID: 20303872)
Allergol Int. 2018 Jan;67(1):12-17. (PMID: 28941636)
PLoS One. 2011;6(10):e26050. (PMID: 22022504)
Eur Respir J. 2016 Mar;47(3):954-66. (PMID: 26743480)
Virus Res. 2011 Dec;162(1-2):12-8. (PMID: 22027189)
Semin Diagn Pathol. 2019 May;36(3):152-159. (PMID: 31054790)
Curr Opin Immunol. 2007 Dec;19(6):711-20. (PMID: 17928212)
J Biol Chem. 1998 Nov 6;273(45):29745-53. (PMID: 9792688)
Am J Physiol Lung Cell Mol Physiol. 2011 Jan;300(1):L25-31. (PMID: 20971803)
J Virol. 2011 Jul;85(13):6795-808. (PMID: 21507984)
EMBO J. 2019 Feb 15;38(4):. (PMID: 30643021)
Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(10):981-988. (PMID: 31436787)
Lancet. 2018 Mar 31;391(10127):1285-1300. (PMID: 29248255)
Semin Immunopathol. 2016 Jul;38(4):471-82. (PMID: 26965109)
J Histochem Cytochem. 2015 May;63(5):312-28. (PMID: 25604814)
J Virol. 2006 Aug;80(16):8060-8. (PMID: 16873262)
Virology. 2010 Jan 20;396(2):178-88. (PMID: 19913271)
Cytokine Growth Factor Rev. 2011 Jun;22(3):121-30. (PMID: 21802343)
Crit Care. 2009;13(6):R201. (PMID: 20003352)
J Immunol Methods. 1988 Nov 25;115(1):61-9. (PMID: 3192948)
Eur Respir J. 2004 Feb;23(2):327-33. (PMID: 14979512)
Cell Host Microbe. 2016 Feb 10;19(2):159-68. (PMID: 26867175)
Cell Death Dis. 2018 Sep 25;9(10):1002. (PMID: 30254192)
Future Virol. 2011 Aug;6(8):951-962. (PMID: 21909336)
Nature. 2018 Jun;558(7711):610-614. (PMID: 29925952)
PLoS One. 2011;6(12):e28680. (PMID: 22174866)
PLoS One. 2010 Jan 15;5(1):e8713. (PMID: 20090947)
Am J Respir Cell Mol Biol. 2012 Aug;47(2):149-57. (PMID: 22383584)
J Virol. 2005 Dec;79(23):14614-21. (PMID: 16282461)
Curr Top Membr. 2018;81:293-335. (PMID: 30243435)
Am J Pathol. 2010 Apr;176(4):1828-40. (PMID: 20110407)
J Interferon Cytokine Res. 2011 Jan;31(1):131-5. (PMID: 21142818)
Eur Respir J. 2015 Apr;45(4):1150-62. (PMID: 25700381)
Mol Immunol. 2011 Jul;48(12-13):1417-23. (PMID: 21497908)
J Allergy Clin Immunol. 2007 Dec;120(6):1233-44; quiz 1245-6. (PMID: 18073119)
Philos Trans R Soc Lond B Biol Sci. 2019 Sep 30;374(1782):20190017. (PMID: 31401954)
Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S143-S148. (PMID: 30431340)
J Cell Sci. 2013 Apr 1;126(Pt 7):1565-75. (PMID: 23418357)
Mol Immunol. 2015 Nov;68(1):28-30. (PMID: 26597202)
Clin Microbiol Rev. 2011 Jan;24(1):210-29. (PMID: 21233513)
Sci Rep. 2015 Oct 07;5:14830. (PMID: 26445169)
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4. (PMID: 15070767)
Am J Physiol Lung Cell Mol Physiol. 2005 Jul;289(1):L85-95. (PMID: 15764644)
Immunity. 2011 May 27;34(5):637-50. (PMID: 21616434)
Virus Res. 2019 Apr 2;263:34-46. (PMID: 30605755)
J Am Heart Assoc. 2014 Feb 26;3(1):e000792. (PMID: 24572259)
J Med Virol. 2014 Jun;86(6):1034-40. (PMID: 24615905)
Physiol Rep. 2015 Apr;3(4):. (PMID: 25847914)
Am J Pathol. 2013 Oct;183(4):1258-1268. (PMID: 23938324)
Sci Rep. 2019 Jan 24;9(1):500. (PMID: 30679531)
Nat Immunol. 2015 Jan;16(1):27-35. (PMID: 25521682)
J R Soc Interface. 2014 Dec 6;11(101):20140950. (PMID: 25401184)
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1294-309. (PMID: 20167850)
Curr Top Microbiol Immunol. 2019;424:1-20. (PMID: 31463536)
Methods Mol Biol. 2013;979:65-70. (PMID: 23397389)
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5040-5. (PMID: 22411804)
Semin Cell Dev Biol. 2014 Dec;36:157-65. (PMID: 25171873)
Lancet Respir Med. 2014 Oct;2(10):813-22. (PMID: 25174549)
Lancet. 2017 Aug 12;390(10095):697-708. (PMID: 28302313)
Vet Pathol. 2006 Sep;43(5):595-612. (PMID: 16966437)
PLoS One. 2013 Nov 14;8(11):e78912. (PMID: 24244384)
Int J Mol Sci. 2018 Jul 16;19(7):. (PMID: 30012970)
Am J Respir Cell Mol Biol. 1996 Jan;14(1):104-12. (PMID: 8534481)
Front Immunol. 2018 Apr 12;9:743. (PMID: 29755452)
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6822-6827. (PMID: 29891677)
Clin Infect Dis. 2010 Mar 15;50(6):850-9. (PMID: 20136415)
J Lab Autom. 2015 Apr;20(2):107-26. (PMID: 25586998)
Cell Host Microbe. 2007 Aug 16;2(2):96-105. (PMID: 18005724)
Respir Res. 2005 Nov 11;6:135. (PMID: 16283933)
PLoS One. 2014 Jul 17;9(7):e100978. (PMID: 25033426)
J Allergy Clin Immunol. 2011 Dec;128(6):1216-1224.e11. (PMID: 21996340)
Annu Rev Virol. 2019 Sep 29;6(1):567-584. (PMID: 31283436)
J Immunol. 1981 May;126(5):1814-9. (PMID: 7217668)
Viruses. 2020 Mar 29;12(4):. (PMID: 32235330)
Biochim Biophys Acta. 2014 Feb;1838(2):595-604. (PMID: 23867773)
Front Immunol. 2015 Jul 20;6:361. (PMID: 26257731)
Curr Opin Cell Biol. 2016 Oct;42:94-101. (PMID: 27236618)
J Biomed Biotechnol. 2012;2012:982971. (PMID: 22523471)
Biochem Soc Trans. 2018 Oct 19;46(5):1099-1106. (PMID: 30154090)
Mediators Inflamm. 2013;2013:495848. (PMID: 23737648)
Semin Immunopathol. 2017 Jul;39(5):541-550. (PMID: 28555383)
Virus Res. 2008 Apr;133(1):33-44. (PMID: 17451829)
J Clin Virol. 2013 Sep;58(1):100-7. (PMID: 23790455)
Adv Drug Deliv Rev. 2019 Feb 1;140:12-32. (PMID: 30009883)
Nature. 2006 May 4;441(7089):101-5. (PMID: 16625202)
J Cell Sci. 2008 Nov 15;121(Pt 22):3677-82. (PMID: 18987354)
Methods Mol Med. 2005;107:183-206. (PMID: 15492373)
PLoS One. 2011;6(6):e21183. (PMID: 21731666)
J Immunol. 2002 May 15;168(10):5278-86. (PMID: 11994485)
Front Physiol. 2019 Jan 23;9:1942. (PMID: 30728783)
Nat Methods. 2016 Feb;13(2):151-7. (PMID: 26689262)
Nature. 2014 Jan 16;505(7483):412-6. (PMID: 24317696)
Sci Rep. 2017 Jun 30;7(1):4475. (PMID: 28667332)
Eur Respir J. 2015 May;45(5):1463-78. (PMID: 25792631)
Cell Tissue Res. 2011 Jan;343(1):13-21. (PMID: 20848130)
Cell Biochem Biophys. 2016 Jun;74(2):191-203. (PMID: 26818810)
Viral Immunol. 2019 Jul/Aug;32(6):244-251. (PMID: 31188076)
J Allergy Clin Immunol. 2010 May;125(5):985-92. (PMID: 20392481)
Viruses. 2020 May 03;12(5):. (PMID: 32375274)
Virus Res. 2015 Nov 2;209:11-22. (PMID: 25678267)
Nat Rev Immunol. 2014 May;14(5):315-28. (PMID: 24762827)
Vaccine. 2000 Dec 8;19 Suppl 1:S32-7. (PMID: 11163460)
Open Biol. 2020 Feb;10(2):190278. (PMID: 32070233)
Science. 2010 Jun 25;328(5986):1662-8. (PMID: 20576885)
Annu Rev Immunol. 2014;32:513-45. (PMID: 24555472)
Am J Pathol. 2007 Oct;171(4):1215-23. (PMID: 17717141)
J Virol. 2008 Mar;82(6):2741-51. (PMID: 18199656)
Respir Res. 2009 Oct 30;10:102. (PMID: 19874627)
Grant Information:
N/A International CSIRO Probing Biosystems Future Science Platform
Contributed Indexing:
Keywords: antiviral; cell death; chemokine; cytokine; cytoskeleton; epithelium; inflammation; innate immune system; lung; tight junction
Substance Nomenclature:
0 (Chemokines)
0 (Cytokines)
0 (MUC5AC protein, human)
0 (Mucin 5AC)
Entry Date(s):
Date Created: 20200701 Date Completed: 20200714 Latest Revision: 20200806
Update Code:
20240105
PubMed Central ID:
PMC7354428
DOI:
10.3390/v12060679
PMID:
32599823
Czasopismo naukowe
The respiratory Influenza A Viruses (IAVs) and emerging zoonotic viruses such as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pose a significant threat to human health. To accelerate our understanding of the host-pathogen response to respiratory viruses, the use of more complex in vitro systems such as normal human bronchial epithelial (NHBE) cell culture models has gained prominence as an alternative to animal models. NHBE cells were differentiated under air-liquid interface (ALI) conditions to form an in vitro pseudostratified epithelium. The responses of well-differentiated (wd) NHBE cells were examined following infection with the 2009 pandemic Influenza A/H1N1pdm09 strain or following challenge with the dsRNA mimic, poly(I:C). At 30 h postinfection with H1N1pdm09, the integrity of the airway epithelium was severely impaired and apical junction complex damage was exhibited by the disassembly of zona occludens-1 (ZO-1) from the cell cytoskeleton. wdNHBE cells produced an innate immune response to IAV-infection with increased transcription of pro- and anti-inflammatory cytokines and chemokines and the antiviral viperin but reduced expression of the mucin-encoding MUC5B , which may impair mucociliary clearance. Poly(I:C) produced similar responses to IAV, with the exception of MUC5B expression which was more than 3-fold higher than for control cells. This study demonstrates that wdNHBE cells are an appropriate ex-vivo model system to investigate the pathogenesis of respiratory viruses.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies